Dexcom announces Team Novo Nordisk partnership. Dexcom stock costs EUR 76.20
Published on 10/03/2026 at 10:40 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
On September 28, 2026, DexCom, Inc. announced a partnership with Team Novo Nordisk under which Dexcom will become the team’s official continuous glucose monitoring partner, according to Dexcom Investor Relations. Dexcom stock was at EUR 76.20 in weekend trading at Lang & Schwarz at 10:39 a.m. CEST on October 3, 2026, up 0.13 percent versus the EUR 76.10 close at Lang & Schwarz on October 2, 2026.
Weekend trading
The Lang & Schwarz bid was EUR 76.00 and the ask was EUR 76.40 at 10:39 a.m. CEST on October 3, 2026. The further course of weekend trading at Lang & Schwarz until 1:00 p.m. CET/CEST is shown by the continuously updated real-time quote of Dexcom stock.
Last Xetra trading day
Lang & Schwarz recorded a close of EUR 76.10 for Dexcom on October 2, 2026. The company’s primary listing is on Nasdaq under the ticker DXCM, according to the company’s investor-relations release.
Company development
Dexcom’s September 28 release also announced its 2026 State of Type 2 Report, issued ahead of the 62nd Annual Meeting of the European Association for the Study of Diabetes. The company said the report surveyed more than 800 healthcare professionals and 2,500 people with Type 2 diabetes across eight countries. It highlighted health literacy, technology literacy and systemic access as challenges in diabetes care. The next Xetra session is scheduled for October 5, 2026.
